FPRX - Five Prime Therapeutics Inc
Previous close
38
0 0%
Share volume: 0
Last Updated: Thu 15 Apr 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$38.00
0.00
0.00%
Summary score
14%
Profitability
0%
Dept financing
8%
Liquidity
36%
Performance
25%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.96%
Return on assets
-9.96%
Return on sales
-1159.17%
Return on invested capital
-17.16%
Total debt ratio
22.07%
Debt ratio change over timeo
-1.05%
Current Ratio
9.02%
Quick Ratio
0%
Cash Position Ratio
1.64%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-17.53%
Return on assets
-10.72%
Return on sales
-1245.64%
Return on invested capital
-79.23%
Total debt ratio
33.21%
Debt ratio change over timeo
-1.38%
Current Ratio
7.18%
Quick Ratio
0%
Cash Position Ratio
2.65%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.12%
Return on assets
-6.68%
Return on sales
0%
Return on invested capital
-54.83%
Total debt ratio
35.29%
Debt ratio change over time
-1.59%
Current Ratio
6.72%
Quick Ratio
0%
Cash Position Ratio
2.93%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-97.75%
Return on assets
-99.91%
Return on sales
1056.07%
Return on invested capital
-43.48%
Total debt ratio
-104.84%
Debt ratio change over time
-1.05%
Current Ratio
1.5%
Quick Ratio
0%
Cash Position Ratio
-1.33%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FPRX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -12.96% | 0% | 0% | 29.06% |
| Return on assets | -9.96% | 0% | 0% | -9.75% |
| Return on sales | -1159.17% | 0% | 0% | -1469.44% |
| Return on invested capital | -17.16% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 22.07% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.05% | 0% | 0% | 19.02% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 7.18% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.65% | 0% | 0% | 5.68% |
| Liquididy | 35% | 0% | 0% | 61% |
| Short-term ratios | FPRX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -17.53% | 0% | 0% | -16.12% |
| Return on assets | -10.72% | 0% | 0% | -14.95% |
| Return on sales | -1245.64% | 0% | 0% | -3498.94% |
| Return on invested capital | -79.23% | 0% | 0% | 96.56% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 33.21% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.38% | 0% | 0% | 0.09% |
| Dept financing | 10% | 0% | 0% | 50% |
| Current Ratio | 7.18% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.65% | 0% | 0% | 5.68% |
| Liquididy | 37% | 0% | 0% | 71% |